https://www.taxtmi.com/news?id=62374 HRV Pharma and MetroChem have entered a multi-year CDMO alliance to jointly develop, scale up, and provide GMP manufacturing for multiple high-value NCE-1 and late-stage complex APIs, with exclusive and semi-exclusive program rights, a pipeline-led framework, and shared responsibilities for end-to-end GMP manufacturing, validation, supply, and global DMF filings; they will co-manage CMC documentation, stability studies, validation programs, and regulatory interactions under a unified quality and audit-readiness program. en-us Fri, 21 Nov 2025 16:46:03 +0530 Fri, 21 Nov 2025 16:46:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=62374 HRV Pharma and MetroChem have entered a multi-year CDMO alliance to jointly develop, scale up, and provide GMP manufacturing for multiple high-value NCE-1 and late-stage complex APIs, with exclusive and semi-exclusive program rights, a pipeline-led framework, and shared responsibilities for end-to-end GMP manufacturing, validation, supply, and global DMF filings; they will co-manage CMC documentation, stability studies, validation programs, and regulatory interactions under a unified quality and audit-readiness program. News - Fri, 21 Nov 2025 16:46:03 +0530 https://www.taxtmi.com/news?id=62374